Sputnik V

Sputnik V

The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement. Photo: Reuters

Sputnik V can offer two-year protection against Covid-19: Developers

According to the Russian scientist, Sputnik V is effective in 96 percent of cases

Russian President Vladimir Putin attends a meeting of the Collective Security Treaty Organization (CSTO), via a video link at the Novo-Ogaryovo state residence outside Moscow, Russia December 2, 2020. Sputnik/Aleksey Nikolskyi/Kremlin via REUTERS

Putin orders Russia to begin large-scale Covid-19 vaccinations next week

Representational image: Reuters

Two-shot of Russia's Sputnik V vaccine to cost less than $20 per person - statement

The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement. Photo: Reuters

Putin says India, China may start producing Russia's Sputnik V Covid-19 vaccine -RIA

South Korean firm to produce 150 million doses of Russian Covid-19 vaccine - RIDF

South Korean firm to produce 150 million doses of Russian Covid-19 vaccine - RIDF

Representational image: Reuters

Russia says its Sputnik V Covid-19 vaccine is 92% effective

Post-registration trials of Russia's second Covid-19 vaccine expected to start on Nov. 15 -deputy PM

Post-registration trials of Russia's second Covid-19 vaccine expected to start on Nov. 15 -deputy PM

Russia's Sputnik V vaccine over 90% effective: health ministry

Russia's Sputnik V vaccine over 90% effective: health ministry

However, the US Food and Drug Administration has said vaccines must demonstrate at least 50% efficacy Representational Photo: BSS/AFP

Russia seeks accelerated WHO registration for virus vaccine

A nurse prepares Russia's "Sputnik-V" vaccine for inoculation in a post-registration trials stage at a clinic in Moscow. Photo: Reuters

Covid-19: India won’t allow trial of Russia’s Sputnik V in large study

A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. Picture taken August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS

First batch of Sputnik V vaccine has been shipped to Russian regions: Health Ministry

A handout photo provided by the Russian Direct Investment Fund (RDIF) shows samples of a vaccine against the coronavirus disease (Covid-19) developed by the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, Russia August 6, 2020. Picture taken August 6, 2020. The Russian Direct Investment Fund (RDIF)/Handout via REUTERS

Russia releases first batch of Covid-19 vaccine Sputnik V into public